European Leaders News

Europe approves first-ever Ebola vaccine

Monday, November 11, 2019 10:46:00 PM

US pharmaceutical maker Merck & Co Inc has received approval from the European Commission to market its Ebola vaccine, less than a month after a European medicines panel backed the first-ever vaccine against the deadly virus. The vaccine, Ervebo, is approved for individuals aged 18 years and....
Europe approves first-ever Ebola vaccine

Monday, November 11, 2019 10:46:00 PM

US pharmaceutical maker Merck & Co Inc has received approval from the European Commission to market its Ebola vaccine, less than a month after a European medicines panel backed the first-ever vaccine against the deadly virus. The vaccine, Ervebo, is approved for individuals aged 18 years and older....
Fortum : British power capacity market a boon for Germany's Uniper

Monday, November 11, 2019 10:43:00 PM

Germany's Uniper on Monday lifted its full-year earnings outlook, seeing itself a beneficiary of the revival of the British power capacity market programme. The British government last month gave the go-ahead to reinstate the power capacity market scheme after the European Commission approved it,....
Merck :'s ERVEBO® [Ebola Zaire Vaccine (rVSVΔG-ZEBOV-GP) live] Granted Conditional Approval in the European Union

Monday, November 11, 2019 10:43:00 PM

Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the European Commission has granted a conditional marketing authorization to ERVEBO for active immunization of individuals 18 years of age or older to protect against Ebola Virus Disease (EVD) caused by Zaire Ebola virus.
Europe approves first-ever Ebola vaccine

Monday, November 11, 2019 10:37:00 PM

US pharmaceutical maker Merck & Co Inc has received approval from the European Commission to market its Ebola vaccine, less than a month after a European medicines panel backed the first-ever vaccine against the deadly virus. The vaccine, Ervebo, is approved for individuals aged 18 years and....
Europe approves first-ever Ebola vaccine

Monday, November 11, 2019 10:34:00 PM

US pharmaceutical maker Merck & Co Inc has received approval from the European Commission to market its Ebola vaccine, less than a month after a European medicines panel backed the first-ever vaccine against the deadly virus. The vaccine, Ervebo, is approved for individuals aged 18 years and older....
Francesca Fellowes

Monday, November 11, 2019 10:32:00 PM

is a senior associate our Data Privacy & Cybersecurity team based in our Leeds office. She has a wealth of experience in advising on a wide spectrum of data privacy issues, including managing large-scale projects involving multiple data flows and advising on commercial arrangements involving complex issues of data ownership and use.
PE : Complaints on the rise

Monday, November 11, 2019 10:28:00 PM

November 11, 2019, 10:24 pm By Ifham Nizam Complaints of election-related incidents had increased to nearly 3,600 by yesterday evening, according to the Elections Commission (EC). Thirty five candidates are in the fray with many of them being dummy contenders, while the actual fight is between the....
PM Hamdok in Brussels, praises EU support for Sudan

Monday, November 11, 2019 10:27:00 PM

Sudan's Prime Minister Dr Abdallah Hamdok travelled to Brussels on Sunday, accompanied by two of his Ministers and other officials. He met with several EU Commissioners and discussed his government’s plans with representatives of the Sudanese community in Belgium.
Ebola Vaccine Approved for Use in Europe

Monday, November 11, 2019 10:16:00 PM

Merck’s Ervebo gets its first regulatory greenlight. A decision from the US Food and Drug Administration is expected in the next few months. E rvebo, an Ebola vaccine from Merck, received marketing approval from the European Commission today (November 11), marking the first such vaccine to reach the world’s markets.
Copyright ©
Updated every 10 minutes, 24 hours per day.

Featured leaders